|IBM Europe||Healthcare and Life Sciences, Industry Leader||United Kingdom|
Leveraging the data generated by medical devices: Which perspectives to fuel innovation in MedTech?
Andrew Fried is IBM European Healthcare and Life Sciences Industry Leader.
From April 2018 through March 2019 Andrew was IBM’s Global Life Sciences Industry Leader. He became European Healthcare and Life Sciences Industry Leader from April 2019.
Andrew helps clients address industry imperatives and save lives through the power of cognitive insights. He works with clients to advance the next generation of discovery and development, acting on insights to drive value, enhance relationships across the ecosystem and empowering people to make better decisions.
Andrew has been IBM’s Life Sciences Industry Leader for Europe between 2015-2108. Prior to transferring to Europe in July 2015, Andrew was IBM Life Sciences Industry Leader for China for 5 years. While in China Andrew worked with many leading multi-national companies and several Chinese Life Sciences companies who were leaders in their respective segment.
Before joining IBM in 2000, Andrew had a successful 14-year career with a leading strategy consulting company. He graduated from Melbourne University with a Bachelor of Arts, and Monash University (Melbourne, Australia) with a Bachelor of Business. Andrew has a Master of Business Administration from the International University of Japan and is a Fellow of the Financial Services Institute of Australasia. He was a three-term board member on a government enterprise with assets of over $350M. He was a founding director of a successful dot.com start-up in the early 2000s.
Andrew is an advocate of sport and fitness as a gateway to good health. He is passionate about the role of genomics in identifying both the cause of disease and personalized solutions.